Pre-clinical pharmacokinetics of the acridine antitumour candidate AC04 and its 1-oxo-metabolite plasma profile

References

• Albert A. (1951). The acridines: their preparation, physical, chemical, and biological properties and uses. London: Hardcover Book.
   Google Scholar
• Brasil. (2008). Lei 11794/08: Procedimentos para Uso Científico de Animais. Diário Oficial da União, Seção 1 de 9 de outubro de; CXLV 196:1:2.
   Google Scholar
• Chilin A, Marzaro G, Marzano C, Dalla Via L, Ferlin MG, Pastorini G, Guiotto A. (2009). Synthesis and antitumor activity of novel amsacrine analogs: the critical role of the acridine moiety in determining their biological activity. Bioorg Med Chem 17:523–529.
   PubMed Web of Science ®Google Scholar
• Ebling WF, Wada DR, Stanski DR.. (1994). From piecewise to full physiologic pharmacokinetic modeling: Applied to thiopenthal disposition in the rat. Pharmacokinet Biopharm 22:259–292.
   Google Scholar
• Evans SM, Robertson IG, Paxton JW. (1994). Plasma protein binding of the experimental antitumour agent acridine-4-carboxamide in man, dog, rat and rabbit. J Pharm Pharmacol 46:63–67.
   PubMed Web of Science ®Google Scholar
• FDA. (2001). Guidance for Industry. Bioanalytical Method Validation. http://www.fda.gov/cder/guidance/index.htm. Accessed on 21 September 2008.
   Google Scholar
• Foster BJ, Wiegand RA, LoRusso PM, Baker LH. (1995). Pharmacokinetics of 9-methoxy-N,N-dimethyl-5-nitropyrazolo [3,4, 5-kl]acridine-2(6H)-propanamine (PZA, PD 115934, NSC 366140) in mice: guidelines for early clinical trials1. Clin Cancer Res 1:831–837.
   PubMed Web of Science ®Google Scholar
• Groothuis DR. (2000). The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery. Neuro-oncology 2:45–59.
   PubMed Web of Science ®Google Scholar
• Guedes FL. (2008). Obtenção dos sistemas de dispersão sólida e complexos de inclusão para solubilização de Benzilideno-Imidazolidina-2,4-Diona e Benzilideno-Tiazolidina-2,4-Diona, Dissertation, Federal University of Pernambuco, Brazil.
   Google Scholar
• Han HK, Sadagopan N, Reichard GA, Yapa U, Zhu T, Hubbel A, Johnson K, Brodfuehrer J. (2006). An efficient approach for the rapid assessment of oral rat exposures for new chemical entities in drug discovery. J Pharm Sci 95:1684–1692.
   Google Scholar
• Hevér A, Santelli-Rouvier C, Brouant P, el Khyari S, Molnár J, Barra Y, Barbe J. (1998). Effect of new thioacridine derivatives on P-gp function and on mdr1 gene expression. Anticancer Res 18:3053–3058.
   Google Scholar
• Huber PC, Maruiama CH, Almeida WP. (2010). Glicoproteína-P, resistência a múltiplas drogas (MDR) e relação estrutura-atividade de moduladores. Quim Nova 33:1–7.
   Google Scholar
• Kaiser M, Azeredo FJ, Uchôa, FDT, Beraldo HO, Dalla Costa T. (2010). Pre-clinical pharmacokinetics evaluation of an anticonvulsant candidate benzaldehyde semicarbazone free and included in β-cyclodextrin. Eur J Pharm Sci 39:355–362.
   Google Scholar
• Leite LFCC, Oliveira BG, Silva TG, Lima MCAl, Hernandes MZ, Galdino SL, Pitta IR. (2006). Docking studies of acridines with anticancer activity. In: Annals of 5th Brazilian Symposium on Medicinal Chemistry (BrazMedChem), São Pedro, São Paulo, Brazil.
   Google Scholar
• Louie AC, Issell BF. (1985). Amsacrine (AMSA)—a clinical review. J Clin Oncol 3:562–592.
   PubMed Web of Science ®Google Scholar
• National Research Council (NRC). (1985). Guide for the Care and Use of Laboratory Animals. NRC. Washington, DC, USA: Department of Health and Human Services, National Institutes of Health. Publ. No. 85-23.
   Google Scholar
• Oppegard LM, Ougolkov AV, Luchini DN, Schoon RA, Goodell JR, Kaur H, Billadeau DD, Ferguson DM, Hiasa H. (2009). Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II. Eur J Pharmacol 602:223–229.
   Google Scholar
• Paxton JW, Kim SN, Whitfield LR. (1990). Pharmacokinetic and toxicity scaling of the antitumor agents amsacrine and CI-921, a new analogue, in mice, rats, rabbits, dogs, and humans. Cancer Res 50:2692–2697.
   PubMed Web of Science ®Google Scholar
• Pigatto MC, Alves de Lima Mdo C, Galdino SL, Pitta Ida R, Vessecchi R, Assis MD, dos Santos JS, Dalla Costa T, Lopes NP. (2011). Metabolism evaluation of the anticancer candidate AC04 by biomimetic oxidative model and rat liver microsomes. Eur J Med Chem 46:4245–4251.
   PubMed Web of Science ®Google Scholar
• Pitta IV, Lima MCA, Galdino SL, Barbe J. (2004). Molecules with antitumor activity and chemical synthesis. Patent No. WO/2004/024058.
   Google Scholar
• Pitta IV, Galdino SL, Lima MCA. (2007). Acridine derivates with antitumoral activity. Patent No. WO/2007/109871.
   Google Scholar
• Rivière GJ, Gentry WB, Owens SM. (2000). Disposition of methamphetamine and its metabolite amphetamine in brain and other tissues in rats after intravenous administration. J Pharmacol Exp Ther 292:1042–1047.
   PubMed Web of Science ®Google Scholar
• Shargel L, Wu-Pong S, Yu ABC. (2005). Applied biopharmaceutics & pharmacokinetics. New York: McGran-Hill.
   Google Scholar
• Sondhi SM, Singh J, Rani R, Gupta PP, Agrawal SK, Saxena AK. (2010). Synthesis, anti-inflammatory and anticancer activity evaluation of some novel acridine derivatives. Eur J Med Chem 45:555–563.
   PubMed Web of Science ®Google Scholar
• Tasso L, Neves G, Menegatti R, Fraga CA, Barreiro E, Eifler-Lima V, Rates SM, Costa TD. (2005). Pharmacokinetics and tissue distribution of a new heterocyclic N-phenylpiperazine derivative (LASSBio-581) in rats. Eur J Pharm Sci 26:194–202.
   PubMed Web of Science ®Google Scholar
• Tetko IV, Bruneau P. (2004). Application of ALOGPS to predict 1-octanol/water distribution coefficients, logP, and logD, of AstraZeneca in-house database. J Pharm Sci 93:3103–3110.
   PubMed Web of Science ®Google Scholar
• Uchôa FD, Haas SE, Brum Junior L, Pigatto MC, Lima MCA, Galdino SL, Pitta IR, Costa TD. (2011). Development and validation of an LC-MS/MS method for the pre-clinical pharmacokinetic investigation of the anticancer candidate AC04 in rodents. J Liquid Chromatogr Relat Technol 34:744–752.
   Web of Science ®Google Scholar
• Vestal RE, Kornhauser DM, Shand DG. (1980). Active uptake of propranolol by isolated rabbit alveolar macrophages and its inhibition by other basic amines. J Pharmacol Exp Ther 214:106–111.
   PubMed Web of Science ®Google Scholar
• Wang W, Ho WC, Dicker DT, MacKinnon C, Winkler JD, Marmorstein R, El-Deiry WS. (2005). Acridine derivatives activate p53 and induce tumor cell death through Bax. Cancer Biol Ther 4:893–898.
   PubMed Web of Science ®Google Scholar